ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is China Resources Pharmaceutical Group Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Operating profit has grown by an annual rate 9.87% of over the last 5 years
- The company is Net-Debt Free
2
Poor long term growth as Operating profit has grown by an annual rate 9.87% of over the last 5 years
3
With ROE of 17.99%, it has a Very Expensive valuation with a 0.52 Price to Book Value
- Over the past year, while the stock has generated a return of -6.52%, its profits have risen by 7.8% ; the PEG ratio of the company is 0.4
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -6.52% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is China Resources Pharmaceutical Group Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
China Resources Pharmaceutical Group Ltd.
-6.52%
-0.72
27.73%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.98%
EBIT Growth (5y)
9.87%
EBIT to Interest (avg)
3.87
Debt to EBITDA (avg)
2.67
Net Debt to Equity (avg)
1.09
Sales to Capital Employed (avg)
1.85
Tax Ratio
23.92%
Dividend Payout Ratio
31.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.46%
ROE (avg)
16.20%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.52
EV to EBIT
7.92
EV to EBITDA
5.99
EV to Capital Employed
0.78
EV to Sales
0.34
PEG Ratio
0.37
Dividend Yield
NA
ROCE (Latest)
9.90%
ROE (Latest)
17.99%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 38,628.73 MM
ROCE(HY)
Highest at 8.08%
NET SALES(Q)
Highest at HKD 150,757.13 MM
RAW MATERIAL COST(Y)
Fallen by -11.11% (YoY
CASH AND EQV(HY)
Highest at HKD 44,049.23 MM
-1What is not working for the Company
DIVIDEND PAYOUT RATIO(Y)
Lowest at 40.52%
Here's what is working for China Resources Pharmaceutical Group Ltd.
Net Sales
Highest at HKD 150,757.13 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Operating Cash Flow
Highest at HKD 38,628.73 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Cash and Eqv
Highest at HKD 44,049.23 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -11.11% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 2,402.68 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 2,402.68 MM has Grown at 18.5%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for China Resources Pharmaceutical Group Ltd.
Dividend Payout Ratio
Lowest at 40.52%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
